Market Cap 1.62B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 3,774,429
Avg Vol 6,170,668
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 94%
Beta 1.02
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon May. 28 at 5:13 PM
$ABCL $XBI - The Biotech ETF is about to break out from a bull flag 🐂 Last time this happened we saw a 15-20% run on the ETF, causing biotech stocks to make amazing moves Added more $ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 5:06 PM
$ABCL $ABCL - Just broke above the 200W SMA for the first time ever!
0 · Reply
Lolichocho
Lolichocho May. 28 at 5:06 PM
$ABCL Ed, waiting for $2...
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 5:05 PM
$ABCL $ABCL So, again if this stays above 5.41 for the week, from a chart perspective, we are in uncharted territory
0 · Reply
Quadruple_Double
Quadruple_Double May. 28 at 5:00 PM
$INMD fully exited today at open, you have to be dynamic in this market or you will miss on real moves. Moved the capital to $ABCL to increase my position before a run up. Can't trust the Israelis anymore. Good business though; if they manage to somehow create new revenue streams.
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 4:54 PM
$ABCL 🤫😉👀 Our favorite biotech has 16 open positions on LinkedIn. One that stands out which was opened/refreshed one week ago is Global Clinical Study Manager.... Well, how might they spend their days.... "Overseeing the global strategy of clinical trials, including study planning, execution, monitoring and close-out." We know that AbCellera is focused on Canada for phase 1 and phase 2 trials... there's only one reason to need a global clinic study manager... and that's for phase 3 trials. At least that's what I'm thinking. This isn't definitive but it makes me think that they are already planning for successful phase 2 in abcl635 so they can quickly move into phase 3. Good luck to all the longs!
0 · Reply
8008track
8008track May. 28 at 4:52 PM
$ABCL interesting… https://x.com/tyler_bosserman/status/2060012705843462348?s=46&t=19IS2lnKv9JueG0DGj5x7Q
0 · Reply
walkitoff
walkitoff May. 28 at 4:45 PM
$ABCL zero to 1
1 · Reply
tranq19
tranq19 May. 28 at 4:33 PM
$ABCL certainly enjoying the run, and expect it to continue to phase 2 results, but that is the potential monumental moment. If they beat on efficacy, first it’s a massive market oppt., but much more importantly validation for the platform. Imagine the excitement on the next 3 trial initiations. All being kept under wraps to maximize their head start. Exciting times
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 4:29 PM
$ABCL You all thought I was crazy? Nah I just know . This is nothing it’s going to be over 10.00 soon. $ABCL
0 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 16 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Q1 Earnings Call Highlights

May 11, 2026, 7:08 PM EDT - 16 days ago

AbCellera Biologics Q1 Earnings Call Highlights


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 16 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 16 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 16 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 16 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 23 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 6 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 7 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 7 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Stocktradesmoon
Stocktradesmoon May. 28 at 5:13 PM
$ABCL $XBI - The Biotech ETF is about to break out from a bull flag 🐂 Last time this happened we saw a 15-20% run on the ETF, causing biotech stocks to make amazing moves Added more $ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 5:06 PM
$ABCL $ABCL - Just broke above the 200W SMA for the first time ever!
0 · Reply
Lolichocho
Lolichocho May. 28 at 5:06 PM
$ABCL Ed, waiting for $2...
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 5:05 PM
$ABCL $ABCL So, again if this stays above 5.41 for the week, from a chart perspective, we are in uncharted territory
0 · Reply
Quadruple_Double
Quadruple_Double May. 28 at 5:00 PM
$INMD fully exited today at open, you have to be dynamic in this market or you will miss on real moves. Moved the capital to $ABCL to increase my position before a run up. Can't trust the Israelis anymore. Good business though; if they manage to somehow create new revenue streams.
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 4:54 PM
$ABCL 🤫😉👀 Our favorite biotech has 16 open positions on LinkedIn. One that stands out which was opened/refreshed one week ago is Global Clinical Study Manager.... Well, how might they spend their days.... "Overseeing the global strategy of clinical trials, including study planning, execution, monitoring and close-out." We know that AbCellera is focused on Canada for phase 1 and phase 2 trials... there's only one reason to need a global clinic study manager... and that's for phase 3 trials. At least that's what I'm thinking. This isn't definitive but it makes me think that they are already planning for successful phase 2 in abcl635 so they can quickly move into phase 3. Good luck to all the longs!
0 · Reply
8008track
8008track May. 28 at 4:52 PM
$ABCL interesting… https://x.com/tyler_bosserman/status/2060012705843462348?s=46&t=19IS2lnKv9JueG0DGj5x7Q
0 · Reply
walkitoff
walkitoff May. 28 at 4:45 PM
$ABCL zero to 1
1 · Reply
tranq19
tranq19 May. 28 at 4:33 PM
$ABCL certainly enjoying the run, and expect it to continue to phase 2 results, but that is the potential monumental moment. If they beat on efficacy, first it’s a massive market oppt., but much more importantly validation for the platform. Imagine the excitement on the next 3 trial initiations. All being kept under wraps to maximize their head start. Exciting times
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 4:29 PM
$ABCL You all thought I was crazy? Nah I just know . This is nothing it’s going to be over 10.00 soon. $ABCL
0 · Reply
Buying_Low_Selling_High
Buying_Low_Selling_High May. 28 at 3:39 PM
$ABCL I expect big attempt tomorrow to push this below $5.64 close. Either way, Phase 2 results is what matters the most. On positive news we are looking at 20-25$ range in my opinion.
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 3:32 PM
$ABCL Bears might want to close their eyes here 😉
0 · Reply
yani09
yani09 May. 28 at 3:28 PM
$ABCL 5.75 then 6.50 next
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 28 at 3:27 PM
$ABCL I don’t think investors are ready for what’s about to happen. If anyone doesn't see this as a golden opportunity to buy, there is no hope for those people $ABCL explosion is coming ✅
0 · Reply
Cassek86
Cassek86 May. 28 at 3:19 PM
$ABCL The bears are really quite here in the last time.
0 · Reply
Reactor_Rebel
Reactor_Rebel May. 28 at 2:38 PM
when $ABCL rockets to $15, how do you look at yourself in the mirror knowing you had the chance and froze? Every thought will spiral back to that hesitation, that moment of weakness. It's the kind of pain you can't explain, but you feel it every single day.💔📷 😭
2 · Reply
DeMampCamp
DeMampCamp May. 28 at 2:33 PM
$ABCL This might be a weird analogy, but this is like smoking a brisket. The internal temp of the brisket moves with ease up until it hits what they call the stall point, once that happens the temp can stay exactly the same for hours, feels like the smoker is broke, but once it finally breaks through that the temp gains momentum again, that is ABCL here in the $5.5XS
2 · Reply
Reactor_Rebel
Reactor_Rebel May. 28 at 2:21 PM
$ABCL this squeeze is gonna be nasty
0 · Reply
bonecrack_benny
bonecrack_benny May. 28 at 2:10 PM
$ABCL She is so strong! Someone is buying small portions att this level… guessing who. The Brothers maybe?
1 · Reply
Stockingtrade
Stockingtrade May. 28 at 1:39 PM
$ABCL With all the market craziness caused by geopolitics, this stock seems like a safe haven.
0 · Reply
8008track
8008track May. 28 at 1:15 PM
$ABCL annoyingly strong. Want to buy more. And friends do too.
1 · Reply
tradersunion353
tradersunion353 May. 28 at 12:49 PM
$ABCL overhyped underperforming junk investors need to see return no just news and hype and stock doesnt move meanwhile who are married to abcl are getting high every day for no reason
1 · Reply